T2 magnetic resonance for fungal diagnosis

Methods in Molecular Biology

Volumn 1508, Issue , 2017, Pages 305-319

  Zervou, Fainareti N ^a   Zacharioudakis, Ioannis M ^a   Kurpewski, Jaclynn ^a   Mylonakis, Eleftherios ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Candida; T2 Candida panel; T2 magnetic resonance; T2MR

Indexed keywords

FUNGAL DNA;

AMPLICON; BLOOD SAMPLING; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CONTROLLED STUDY; FUNGAL DETECTION; GENE AMPLIFICATION; MOLECULAR DIAGNOSTICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PICHIA KUDRIAVZEVII; SPECIES IDENTIFICATION; BLOOD; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

CANDIDEMIA; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 84995511594     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-6515-1_18     Document Type: Chapter

References (20)

1. Miceli MH, Diaz JA, Lee SA (2011) Emerging opportunistic yeast infections. Lancet Infect Dis 11:142-151
2. Magill SS, Edwards JR, Bamberg W et al (2014) Multistate point-prevalence survey of health care-associated infections. N Engl J Med 370:1198-1208
3. Andes DR, Safdar N, Baddley JW et al (2012) Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 54:1110-1122
4. Garey KW, Rege M, Pai MP et al (2006) Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multiinstitutional study. Clin Infect Dis 43:25-31
5. Morrell M, Fraser VJ, Kollef MH (2005) Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49:3640-3645
6. Aitken SL, Beyda ND, Shah DN et al (2014) Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics. Ann Pharmacother 48:683-690
7. Arvanitis M, Anagnostou T, Fuchs BB et al (2014) Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev 27:490-526
8. Kourkoumpetis TK, Fuchs BB, Coleman JJ et al (2012) Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections. Clin Infect Dis 54:1322-1331
9. Walsh TJ, Teppler H, Donowitz GR et al (2004) Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 351:1391-1402
10. Garnacho-Montero J, Diaz-Martin A, Garcia- Cabrera E et al (2010) Risk factors for fluconazole- resistant candidemia. Antimicrob Agents Chemother 54:3149-3154
11. Beyda ND, Lewis RE, Garey KW (2012) Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches. Ann Pharmacother 46: 1086-1096
12. Alexander BD, Johnson MD, Pfeiffer CD et al (2013) Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis 56:1724-1732
13. Neely LA, Audeh M, Phung NA et al (2013) T2 magnetic resonance enables nanoparticlemediated rapid detection of candidemia in whole blood. Sci Transl Med 5:182ra54
14. Beyda ND, Alam MJ, Garey KW (2013) Comparison of the T2Dx instrument with T2 Candida assay and automated blood culture in the detection of Candida species using seeded blood samples. Diagn Microbiol Infect Dis 77:324-326
15. Mylonakis E, Clancy CJ, Ostrosky-Zeichner L et al (2015) T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis 60: 892-899
16. Pfaller MA, Jones RN, Castanheira M (2014) Regional data analysis of Candida non-albicans strains collected in United States medical sites over a 6-year period, 2006-2011. Mycoses 57:602-611
17. Pappas PG, Kauffman CA, Andes D et al (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48:503-535
18. Farmakiotis D, Tarrand JJ, Kontoyiannis DP (2014) Drug-resistant Candida glabrata infection in cancer patients. Emerg Infect Dis 20: 1833-1840
19. Mylonakis E, Clancy CJ, Ostrosky-Zeichner L et al (2015) Reply to Bauer and Goff. Clin Infect Dis 61:487-488
20. Bilir SP, Ferrufino CP, Pfaller MA et al (2015) The economic impact of rapid Candida species identification by T2 Candida among high-risk patients. Future Microbiol 10:1133-1144